These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 8000967)
1. Cryptococcus neoformans infection can elicit protective antibodies in mice. Mukherjee J; Scharff MD; Casadevall A Can J Microbiol; 1994 Oct; 40(10):888-92. PubMed ID: 8000967 [TBL] [Abstract][Full Text] [Related]
2. Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans. Zebedee SL; Koduri RK; Mukherjee J; Mukherjee S; Lee S; Sauer DF; Scharff MD; Casadevall A Antimicrob Agents Chemother; 1994 Jul; 38(7):1507-14. PubMed ID: 7979280 [TBL] [Abstract][Full Text] [Related]
3. Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans. Beenhouwer DO; Shapiro S; Feldmesser M; Casadevall A; Scharff MD Infect Immun; 2001 Oct; 69(10):6445-55. PubMed ID: 11553589 [TBL] [Abstract][Full Text] [Related]
4. Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection. Mukherjee J; Pirofski LA; Scharff MD; Casadevall A Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3636-40. PubMed ID: 8475112 [TBL] [Abstract][Full Text] [Related]
5. Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles. Maitta RW; Datta K; Chang Q; Luo RX; Witover B; Subramaniam K; Pirofski LA Infect Immun; 2004 Aug; 72(8):4810-8. PubMed ID: 15271943 [TBL] [Abstract][Full Text] [Related]
6. Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains. Mukherjee J; Scharff MD; Casadevall A Infect Immun; 1995 Sep; 63(9):3353-9. PubMed ID: 7642262 [TBL] [Abstract][Full Text] [Related]
7. Effect of antibody to capsular polysaccharide on eosinophilic pneumonia in murine infection with Cryptococcus neoformans. Feldmesser M; Kress Y; Casadevall A J Infect Dis; 1998 Jun; 177(6):1639-46. PubMed ID: 9607844 [TBL] [Abstract][Full Text] [Related]
8. Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody. Dromer F; Charreire J; Contrepois A; Carbon C; Yeni P Infect Immun; 1987 Mar; 55(3):749-52. PubMed ID: 3546140 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice. Mukherjee S; Lee S; Mukherjee J; Scharff MD; Casadevall A Infect Immun; 1994 Mar; 62(3):1079-88. PubMed ID: 8112842 [TBL] [Abstract][Full Text] [Related]
10. An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo. Rachini A; Pietrella D; Lupo P; Torosantucci A; Chiani P; Bromuro C; Proietti C; Bistoni F; Cassone A; Vecchiarelli A Infect Immun; 2007 Nov; 75(11):5085-94. PubMed ID: 17606600 [TBL] [Abstract][Full Text] [Related]
11. Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody. Yuan R; Casadevall A; Spira G; Scharff MD J Immunol; 1995 Feb; 154(4):1810-6. PubMed ID: 7836766 [TBL] [Abstract][Full Text] [Related]
12. Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide. Sanford JE; Lupan DM; Schlageter AM; Kozel TR Infect Immun; 1990 Jun; 58(6):1919-23. PubMed ID: 2341184 [TBL] [Abstract][Full Text] [Related]
13. Cryptococcus neoformans: paradigm for the role of antibody immunity against fungi? Pirofski LA; Casadevall A Zentralbl Bakteriol; 1996 Aug; 284(4):475-95. PubMed ID: 8899968 [TBL] [Abstract][Full Text] [Related]
16. Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell. Mukherjee J; Nussbaum G; Scharff MD; Casadevall A J Exp Med; 1995 Jan; 181(1):405-9. PubMed ID: 7807020 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of immune sera from human immunoglobulin transgenic mice immunized with a peptide mimotope of Cryptococcus neoformans glucuronoxylomannan. Maitta RW; Datta K; Pirofski LA Vaccine; 2004 Sep; 22(29-30):4062-8. PubMed ID: 15364457 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B. Mukherjee J; Zuckier LS; Scharff MD; Casadevall A Antimicrob Agents Chemother; 1994 Mar; 38(3):580-7. PubMed ID: 8203858 [TBL] [Abstract][Full Text] [Related]
19. A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection. Fleuridor R; Lees A; Pirofski L J Immunol; 2001 Jan; 166(2):1087-96. PubMed ID: 11145689 [TBL] [Abstract][Full Text] [Related]